| Cardiovascular Risk Management |
1 |
1 |
| Restenosis |
0 |
0.99 |
| Stent |
0 |
0.57 |
| Drug-Eluting Stent |
0 |
0.47 |
| Thromboembolism |
0 |
0.45 |
| Cardiac Surgery |
0 |
0.43 |
| Angina Pectoris |
0 |
0.41 |
| Hypertension |
0 |
0.38 |
| Cardiovascular Imaging |
0 |
0.33 |
| Heart |
0 |
0.29 |
| Antithrombotics |
0 |
0.26 |
| Nitric Oxide |
0 |
0.19 |
| Stable Angina |
0 |
0.19 |
| Platelet Reactivity |
0 |
0.14 |
| Lipids Management |
0 |
0.12 |
| Angiography |
0 |
0.1 |
| Artery |
0 |
0.1 |
| Body Mass Index |
0 |
0.1 |
| Geriatrics |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Hypercholesterolemia |
0 |
0.1 |
| Interventional Cardiology |
0 |
0.1 |
| New York |
0 |
0.1 |
| Platelet Count |
0 |
0.1 |
| Target Vessel Revascularization |
0 |
0.1 |
| Thrombosis |
0 |
0.1 |
| Washington |
0 |
0.1 |
| Weakness |
0 |
0.1 |